Savara Reports Third Quarter 2024 Financial Results and Provides Business Update
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third ...
The American Journal of Managed Care5d
Fexagratinib in MS Shows Promise for Human Use
Previous research has highlighted the roles of the FGF, CSF, and VEGF signaling pathways in the pathology of MS. “In chronic ...
Armed robbery in Revesby6d
CSF Multi-omics Reveals Lipid Role in Stroke Recovery
This study is led by Professor Rong Hu's team from the Department of Neurosurgery and Key Laboratory of Neurotrama, Southwest Hospital, Third Military ...
manilatimes6d
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
Bria-OTS+™ further expresses multiple immune activating cytokines and co-stimulatory molecules in addition to immune boosting granulocyte-macrophage colony-stimulating factor (GM-CSF). The Bria-OTS+™ ...
News Medical6d
Understanding metabolic alterations and immune dysfunction in acute-on-chronic liver failure
Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute deterioration of liver function ...
EurekAlert!6d
CSF multi-omics of intracerebral hemorrhage from onset to reperfusion underscores lipid metabolism in functional outcome
In a paper published in Science Bulletin, multi-omics analyses comprising of lipidomics (439 lipids), sterolomics (22 ...